Home / Research library / GHRP-6
GHRP-6: molecular data, studies & sources
GHRP-6 is catalogued here as a research compound. This profile brings together the molecular source record, selected indexed publications and available supplier comparisons. Evidence for a named substance does not authenticate a commercial product.
Compiled by PeptideTech Editors · Sources checked · Selected bibliography, not a systematic review
Molecular formula, weight & structure
- Molecular formula (MF)
- C46H56N12O6
- Molecular weight (MW)
- 873.0 g/mol
- PubChem compound ID
- 4345065
- Record title
- Ghrp-6
Values describe the selected PubChem molecular entity. Counterions, salt forms, hydration and sequence changes can alter the supplied material. Confirm the exact identity against the supplier specification.
Source: PubChem CID 4345065 · retrieved 2026-09-21

Chemical identifiers and source data
- IUPAC name
- 6-amino-2-[[2-[[2-[2-[[2-[[2-amino-3-(1H-imidazol-5-yl)propanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]propanoylamino]-3-(1H-indol-3-yl)propanoyl]amino]-3-phenylpropanoyl]amino]hexanamide
- InChIKey
- WZHKXNSOCOQYQX-UHFFFAOYSA-N
- SMILES
- CC(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC3=CC=CC=C3)C(=O)NC(CCCCN)C(=O)N)NC(=O)C(CC4=CNC5=CC=CC=C54)NC(=O)C(CC6=CN=CN6)N
Identifiers & sequence
Peptide sequence · 6 residues (one-letter code; X marks a residue without a one-letter code)
HWAWFK
Condensed notation with terminal groups and non-standard residues
H-DL-His-DL-Trp-DL-Ala-DL-Trp-DL-Phe-DL-Lys-NH2
Source: PubChem Biologic Line Notation. A reference sequence for the record, not an analysis of a supplied batch.
Calculated molecular descriptors
| Monoisotopic (exact) mass | 872.4446 Da |
|---|---|
| Heavy atoms | 64 |
| Hydrogen-bond donors | 11 |
| Hydrogen-bond acceptors | 9 |
| Rotatable bonds | 23 |
| Topological polar surface area | 300.9 Ų |
| Calculated logP (Crippen) | 1.03 |
| Rings | 6 |
| Stereocenters | 6 |
| Formal charge | 0 |
Computed with RDKit from the published SMILES (Crippen logP, topological polar surface area). Calculated descriptors are not measured properties of a supplied batch.
Registered clinical trials
Studies registered on ClinicalTrials.gov that list GHRP-6 as an intervention. Studies that only measure the molecule as a biomarker, or use it only as a comparator or background arm for another drug, are excluded. A registration describes a planned or completed protocol; it does not report a result. Active studies are listed first.
No registered study naming this compound was matched. This is a documented gap in registry coverage, not proof that no study exists.
Registry check 2026-10-01 · Run this search on ClinicalTrials.gov
Human intervention studies
Selected studies in which participants received GHRP-6, with their indexed or reviewed study type. Check the original article for the formulation, population and controls. Studies that only measured the molecule, or used it as a comparator, are listed separately below and are not counted as intervention studies.
- Human study · PubMed trial index Compound given to participants
Ghrelin and GHRP-6-induced ACTH and cortisol release in thyrotoxicosis.
Nascif SO, Molica P, Correa-Silva SR et al. · Pituitary · 2009
PMID 19396632 · DOI: 10.1007/s11102-009-0181-3
Preclinical research, reviews & other publications
Animal studies, laboratory experiments, reviews and other indexed papers answer different questions. A review is secondary evidence; a case report does not estimate how often an outcome occurs.
- Review · secondary evidence
Growth hormone releasing hexapeptide-6 (GHRP-6) test in the diagnosis of GH-deficiency.
Pombo M, Leal-Cerro A, Barreiro J et al. · Journal of pediatric endocrinology & metabolism : JPEM · 1996
PMID 8887178
GHRP-6 supplier sources
Scientific sources describe molecules and experiments. The commercial links below identify recorded supplier packages. A publication or chemical database entry does not verify the seller, purity, sterility or contents of a lot. Some links are affiliate links; see our disclosure.
GHRP-6 for sale: compare prices, sizes and forms from every tracked supplier →
| Supplier | Recorded packages | Example source listing |
|---|---|---|
| Amino USAUSD | 5mg Vial1 recorded offers | 5mg Vial · $15.00Checked Nov 6, 2026Supplier listing, GHRP-6 5mg Vial, Amino USA, opens in a new tab |
| Cenexa LabsUSD | 5mg Vial · 10mg Vial2 recorded offers | 5mg Vial · $24.99Checked Nov 6, 2026Supplier listing, GHRP-6 5mg Vial, Cenexa Labs, opens in a new tab |
Reference sources & further reading
- PubChem compound record 4345065 — chemical identity and structure.
- Wikipedia: GHRP-6 — Background encyclopedia; not a primary clinical source.
The citations above link directly to publication records. Encyclopedia links are background reading and are not used to establish clinical effectiveness.
Search for additional research
These links run searches; their results have not been individually reviewed and can include unrelated compounds.
Research information is not a dosing guide or a recommendation for personal use. Study findings are specific to the formulation, population and methods tested. Read our source and correction policy.
Related research profiles
CJC-1295 (DAC)
C165H269N47O46
3647.2 g/mol · PubChem CID 91971820
2 selected publications · 2 human intervention studies · 1 registered trial
CJC-1295 (No DAC)
Molecular identity needs further verification
Source verification pending
0 selected publications · 0 human intervention studies
GHRP-2
C45H55N9O6
818.0 g/mol · PubChem CID 6918245
8 selected publications · 2 human intervention studies
Protein / peptide · highest stage: Phase 2
Hexarelin
C47H58N12O6
887.0 g/mol · PubChem CID 6918297
6 selected publications · 5 human intervention studies
Protein / peptide · highest stage: Phase 2
IGF-1 DES
Molecular identity needs further verification
5 selected publications · 0 human intervention studies
IGF-1 LR3
Molecular identity needs further verification
2 selected publications · 0 human intervention studies